seen from United States
seen from Malaysia
seen from United States
seen from China
seen from China
seen from United States
seen from Germany
seen from United States
seen from Netherlands
seen from France
seen from Spain
seen from China
seen from China
seen from Malaysia
seen from Netherlands
seen from United States
seen from Malaysia
seen from Malaysia
seen from China
seen from Malaysia
My Fafner model collection!
I finally got around to assembling all of the Soukyuu no Fafner models I have. The mechs from Fafner are all amazing, but Mark Sein, Mark Nicht, and Mark Alles are my absolute favorites! I'll be able to put them in more poses after the stands arrive in the mail.
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
The congresswoman relentlessly grilled the former Celgene CEO for earning bonuses off the backs of cancer patients.
Josephine Harvey at HuffPost:
Rep. Katie Porter (D-Calif.) and her trusty whiteboard are at it again.
The lawmaker delivered one of her textbook takedowns during a House Committee on Oversight and Reform hearing Wednesday with current and former executives of three major drug companies. The committee is investigating the high cost of prescription drugs in the U.S.
Porter began her grilling of Mark Alles, the CEO of Celgene until 2019, by asking about the company’s repeated price hikes of the cancer drug Revlimid. It now costs $763 per pill ― up from $215 in 2005.
Alles explained that the drug was approved for new indications, but Porter stopped him to ask if that had changed the pill in any way.
“Did the drug start to work faster?” she asked. “Were there fewer side effects? How did you change the formula or production of Revlimid to justify this price increase?”
Alles said the manufacturing of the pill remained the same.
